Clinical Trials Logo

Halitosis clinical trials

View clinical trials related to Halitosis.

Filter by:

NCT ID: NCT04998617 Completed - Halitosis Clinical Trials

Effects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis

Start date: May 24, 2022
Phase: N/A
Study type: Interventional

Purpose: To investigate the short-term clinical effect of curcumin-containing toothpaste on halitosis as compared to placebo and to assess potential shifts in the composition of dental biofilm associated with the use of curcumin-containing toothpaste Participants: This clinical study will 30 adult participants under prophylactic or periodontal maintenance protocol. Procedures (methods): Participants will be included and throughout the protocol will not allow the use any other oral hygiene products except standard manual toothbrush and study toothpaste (either test -curcumin-containing or placebo). Additionally participants will be instructed to odiferous foods such as onions, garlic and spices. At each of the three examination sessions, Plaque Index (six sites, O'Leary) and volatile sulphur compounds (VSC) will be measured.

NCT ID: NCT04914208 Completed - Halitosis Clinical Trials

Effect of Wearing Face Masks on Salivary Parameters and Halitosis

Start date: September 28, 2021
Phase: N/A
Study type: Interventional

During the current COVID-19 pandemic, the use of face masks is recommended / mandatory to prevent infection. Patients and students have reported to experience limitations in their oral health-related quality of life, especially with regard to the occurrence of dry mouth and halitosis, while wearing face masks. Scientific studies regarding the effects of face masks have so far focused exclusively on medical staff. Studies among the general population are not yet available, but are of interest as dry mouth is a risk factor for dental diseases (e.g., caries, erosion). Therefore, the present study aims at measuring the effect of wearing different face masks on salivary parameters (unstimulated and stimulated saliva flow rate, pH, buffer capacity) and halitosis (volatile sulphur compounds).

NCT ID: NCT04905940 Not yet recruiting - Halitosis Clinical Trials

Evaluation of Clinical and Cost-effectiveness of Different Mouthwashes on Controlling Halitosis Among a Group of Egyptian Children

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

To evaluate the clinical and cost-effectiveness of mouthwash containing Curcuma longa (Turmeric extract) versus mouthwash containing essential oils and Placebo mouthwash on controlling Halitosis among a group of Egyptian children.

NCT ID: NCT04779502 Completed - Halitosis Clinical Trials

The Efficacy of Oregano Essential Oil in Reducing Oral Halitosis

Start date: January 12, 2020
Phase: N/A
Study type: Interventional

the efficacy of commercially available oregano essential oil mouthwash in the reduction of oral halitosis was compared to chlorhexidine and distilled water and the results showed significant reduction of organoleptic tongue and floss scores and BANA test scores compared to placebo

NCT ID: NCT04632004 Completed - Halitosis Clinical Trials

Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health

Start date: November 20, 2020
Phase: N/A
Study type: Interventional

During the current COVID-19 pandemic, the use of face masks is recommended / mandatory to prevent infection. Patients and students have reported to experience limitations in their oral health-related quality of life, especially with regard to the occurrence of dry mouth and halitosis, while wearing face masks. Scientific studies regarding the effects of face masks have so far focused exclusively on medical staff. Studies among the general population are not yet available, but are of interest as dry mouth is a risk factor for dental diseases (e.g., caries, erosion). Therefore, the present study aims at performing a questionnaire survey regarding self-perceived dry mouth and halitosis and the use of face masks (type, wearing time).

NCT ID: NCT04589481 Completed - Bad Breath Clinical Trials

Effectiveness of Different Candies Against Bad Breath

HALIDROP
Start date: February 23, 2021
Phase: N/A
Study type: Interventional

This study is to analyze whether the candies can relieve or eliminate bad breath, both subjectively and objectively.

NCT ID: NCT04473404 Completed - Halitosis Clinical Trials

Effect of a Probiotic Water on Oral Health in Adults

Start date: July 20, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of consuming a probiotic on salivary, plaque, and tongue bacteria, as well as oral malodor (bad breath). Healthy volunteers will consume a probiotic powder, or a placebo powder, that is dissolved in water for 4 weeks.

NCT ID: NCT04279106 Completed - Halitosis Clinical Trials

Effect of Single Rinsing With Three Different Types of Mouthwash on VSC Levels in Morning Breath

Start date: September 3, 2018
Phase: N/A
Study type: Interventional

Morning bad breath (MBB) is often an enduring upset; this double blind, crossover, randomized study aimed to evaluate the bad breath-suppressing of 3 commercially available mouth rinses (Mentadent Professional® 0.05%chlorhexidine (MPc), Meridol® Halitosis (MH) and CB12®) and a placebo on morning halitosis during a washout period of 1 week.

NCT ID: NCT04216069 Not yet recruiting - Dental Plaque Clinical Trials

Efficacy of Different Toothbrushes and Hygiene Regimen

Start date: January 5, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

To evaluate: 1) Evaluate the efficacy of a regimen commercially available versus brush alone on established plaque and gingivitis on adolescents. The Group 1 will use the following procedure: Colgate Ultrasoft toothbrush, Colgate Total 12 toothpaste and Plax Mouthwash, and the other Group will use Colgate Ultrasoft toothbrush and Colgate Cavity Protection toothpaste; 2) The level of halitosis. Two calibrated and blinded examiners (Cohen Kappa 85%) will evaluate the gingival condition using the visible plaque indices, a simplified oral hygiene index - IHOS and gingival bleeding index, with the aid of a WHO probe. For the evaluation of halitosis levels, all individuals will respond to a questionnaire regarding personal data, general and oral health, which includes hygiene habits and received previous guidelines for the procedures to be performed in the second moment. At the next consultation, subjects will be assessed clinically for halitosis using the portable BreathAlert™ sulfide monitor (Tanita Corporation, Japan), in addition to the evaluation of the tongue flap index (ISL), pH and salivary flow. The evaluations will be in the following periods: baseline, 1, 3 and 6 months of brushing. Data will be submitted to descriptive statistical analysis to demonstrate the distributions frequency of biofilm indices and gingival bleeding. The differences in the criteria evaluated will be submitted to Fisher's exact test (α = 0.05) and their performance at different times will be evaluated by the Mann-Whitney test (α = 0.05).

NCT ID: NCT04120948 Completed - Halitosis Clinical Trials

Laser Tongue Debridement for Oral Malodor

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Malodor is a multifactorial condition with oral pathology representing the main culprit and the tongue being the first to second contributor to the malodor. Bacterial load can represent a quantifiable measure regardless of the original pathology. It is hypothesized that reduction in malodor can be represented by tongue changes both in appearance, bacterial and biofilm load reduction (measured by CFU and volatile gases measurement), organoleptic measurement and subjective improvement. Methods: A randomized controlled prospective study under IRB approval. Diagnostic criteria for enrollment and follow up were organoleptic test by 2 judges, halimeter reading, tongue colores changes HALT questionnaire and direct aerobic and anaerobic tongue cultures measured by CFU. Patients were treated with laser tongue debridement (LTD) with an Er,Cr:YSGG solid state laser has been shown to be effective in biofilm reduction.